Skip to main content

Table 1 Clinical characteristics of the patients carrying c.1663G > A (p.A555T)

From: A rare mutation c.1663G > A (p.A555T) in the MMUT gene associated with mild clinical and biochemical phenotypes of methylmalonic acidemia in 30 Chinese patients

Case no

Sex

Age

NS

Age of beginning to treat

Disease onset

Age at onset

Current health status

Hydroxocobalamin effective

P1

F

13 ys

Yes

1 m

No

Healthy

Yes

P2

M

5 ys

Yes

4 ms

No

Healthy

Yes

P3

M

3 ys

Yes

3 ms

No

Healthy

Yes

P4

F

3 ys

Yes

1 m

No

Healthy

Yes

P5

M

1 y

Yes

3.7 ms

No

Healthy

Yes

P6

M

11 ms

Yes

1 m

No

Healthy

Yes

P7

M

1 y

Yes

1 m

No

Healthy

Yes

P8

F

2.5 ys

Yes

1 m

No

Healthy

Yes

P9

M

4 ys

No

23 ms

Yes

DD

Intellectual impairment

Yes

P10

F

4 ys

Yes

1.7 ms

No

Healthy

Yes

P11

F

8 ms

Yes

1 m

No

Healthy

Yes

P12

M

7 ms

Yes

1 m

No

Healthy

Yes

P13

F

3.4 ys

No

3ys

No

Healthy

Not used

P14

F

3 ys

Yes

2 ms

No

Healthy

Yes

P15

F

4 ys

Yes

1y

Yes

DD

Intellectual impairment

Yes

P16

M

3 ys

Yes

1.3 ms

No

Healthy

Yes

P17

M

2 ys

Yes

1.3 ms

No

Healthy

Yes

P18

M

8 ys

No

4.5ys

Yes

DD

Intellectual impairment

Yes

P19

F

3.5 ys

Yes

1 m

Yes

1.8y

Healthy

Yes

P20

M

4.2 ys

Yes

4 ms

No

Loss of follow up

Yes

P21

M

3 ys

Yes

1.4 ms

No

Healthy

Yes

P22

M

2 ys

Yes

1 m

No

Healthy

Yes

P23

F

1 ys

Yes

4 ms

No

Healthy

Yes

P24

M

1.6 ys

Yes

1.3 ms

Yes

DD

Developmental delay

Yes

P25

F

2.6 ys

Yes

20 ds

No

Healthy

Yes

P26

F

2.5 ys

Yes

2 ms

No

Healthy

Yes

P27

F

1 ys

Yes

1 m

No

Healthy

Yes

P28

M

2 ys

Yes

1 m

No

Healthy

Yes

P29

M

2 ys

Yes

16 ms

Yes

16 ms

Healthy

Yes

P30

M

14 ys

No

2.5 ms

Yes

1 m

Loss of follow up

Yes

Case no

On presentation

After treatment

Mutation 1

Mutation 2

C3

C3/C2

Methylmalonic acid

Methylcitric acid

C3

C3/C2

Methylmalonic acid

Methylcitric acid

P1

7.92

0.69

566.23

4.38

3.29

0.26

22.40

1.27

c.1663G > A, p.A555T

c.729_730insTT, p.D244Lfs*39

P2

6.06

0.31

2.31

1.92

3.88

0.23

4.55

1.75

c.1663G > A, p.A555T

c.729_730insTT,p.D244Lfs*39

P3

4.89

0.33

4.62

2.967

0.16

<1

0.27

c.1663G > A, p.A555T

c.729_730insTT,p.D244Lfs*39

P4

6.98

0.69

84.50

6.781

0.354

47

1.1

c.1663G > A, p.A555T

c.729_730insTT,p.D244Lfs*39

P5

4.95

0.32

18

1.08

2.51

0.08

9.44

<1

c.1663G > A, p.A555T

c.729_730insTT,p.D244Lfs*39

P6

7.88

0.49

27

1.1

8.52

0.16

30

1.62

c.1663G > A, p.A555T

c.729_730insTT,p.D244Lfs*39

P7

3.8

0.52

228.11

9.68

1.83

0.1

2.1

<1

c.1663G > A, p.A555T

c.729_730insTT,p.D244Lfs*39

P8

6.67

0.69

94.31

2.20

0.17

0.90

c.1663G > A, p.A555T

c.1106G > A,p.R369H

P9

3.86

0.34

6.2

0

3.3

0.25

0.3

<1

c.1663G > A, p.A555T

c.1106G > A,p.R369H

P10

7.11

0.72

124.80

2.15

0.28

2.06

0.36

c.1663G > A, p.A555T

c.1106G > A,p.R369H

P11

5.82

0.18

20.09

2.2

1.31

0.07

1.32

0.56

c.1663G > A, p.A555T

c.1106G > A,p.R369H

P12

4.63

0.23

34.6

1.4

1.903

0.113

18.9

c.1663G > A, p.A555T

c.2131G > T,p.E711X

P13

3.97

0.27

5.7

0.8

6.3

0.22

15

0.9

c.1663G > A, p.A555T

c.2131G > T,p.E711X

P14

5.02

0.38

3.8

0.2

c.1663G > A, p.A555T

c.2131G > T,p.E711X

P15

9.72

0.51

38.96

1.2

7.17

0.26

4.28

0.53

c.1663G > A, p.A555T

c.424A > G,p.T142A

P16

4.86

0.37

9.27

1.33

2.188

0.09

<1

0.11

c.1663G > A, p.A555T

c.424A > G,p.T142A

P17

8.65

0.7

133.91

2.26

5.87

0.2

c.1663G > A, p.A555T

c.494A > G,p.D165G

P18

3.01

0.19

43.77

2.46

0.11

1.1

<1

c.1663G > A, p.A555T

c.613G > A,p.E205K

P19

7.81

0.92

100.08

3.78

5.42

0.3

3

0.13

c.1663G > A, p.A555T

c.626dupC,p.K210X

P20

4.13

0.69

63.82

0.42

4.30

0.30

85.17

4.2

c.1663G > A, p.A555T

c.755_756insA,p.H252Qfs*6

P21

6.76

0.62

286.19

4.22

2.92

0.06

12.77

1.01

c.1663G > A, p.A555T

c.914T > C,p.L305S

P22

6.54

0.33

92.69

2.58

1.96

0.06

13.4

0.6

c.1663G > A, p.A555T

c.1207C > T,p.R403*

P23

5.94

0.45

43.25

2.384

0.149

3.25

<1

c.1663G > A, p.A555T

c.1233_1235delCAT,p.I411-

P24

5.85

0.39

22.31

1.5

7.26

0.15

2.93

0.63

c.1663G > A, p.A555T

c.1280G > A,G427D

P25

4.1

0.34

8.5

0

7.41

0.2

33

1.1

c.1663G > A, p.A555T

1679G > A,C560Y

P26

2.4

0.32

45.6

1.07

1.78

0.1

<1

<1

c.1663G > A, p.A555T

c.2009G > T,p.G670V

P27

5.82

0.30

28.80

2.16

4.426

0.133

3.79

<1

c.1663G > A, p.A555T

E13 deletion

P28

4.71

0.41

29.7

0.7

4.93

0.2

77.7

2

c.1663G > A, p.A555T

Not detected

P29

4.67

0.34

174.7

0.89

3.16

0.13

7.25

<1

c.1663G > A, p.A555T

Not detected

P30

6.55

0.85

1.85

0.31

c.1663G > A, p.A555T

Not detected

  1. M, male; F, female; NS, Newborn Screening; DD, progressive developmental delay; y, year; m, month; d, day
  2. Typical reference range of C3 in the blood:0.50–4.00 μmol/L; Typical reference range of C3/C2 in the blood:0.04–0.25; Typical reference range of methylmalonic acid in the urine:0–4 mmol/mol creatinine; Typical reference range of methylcitric acid in the urine: 0–0.8 mmol/mol creatinine
  3. –, not available